首页> 外文期刊>Patient Preference and Adherence >Patient Perspectives on Factors Influencing Medication Adherence Among People with Coronary Heart Disease (CHD) and CHD Risk Factors
【24h】

Patient Perspectives on Factors Influencing Medication Adherence Among People with Coronary Heart Disease (CHD) and CHD Risk Factors

机译:患者对影响冠心病(CHD)和CHD危险因素的人们影响药物依恋的因素

获取原文
获取外文期刊封面目录资料

摘要

Background: Few qualitative studies have explored factors influencing medication adherence among people with coronary heart disease (CHD) or CHD risk factors. We explored how factors related to the patient (e.g. self-efficacy), social/economic conditions (e.g. social support and cost of medications), therapy (e.g. side effects), health condition (e.g. comorbidities), and the healthcare system/healthcare team (e.g. support from healthcare providers and pharmacy access) influence medication adherence, based on the World Health Organization Multidimensional Adherence Model (WHO-MAM). Methods: We conducted 18 in-depth qualitative interviews from April to July 2018 with ambulatory care patients aged ≥45 years (8 black men, 5 black women, 2 white men, and 3 white women) who were using medications for diabetes, hypertension, dyslipidemia and/or CHD. We used thematic analysis to analyze the data, and sub-themes emerged within each WHO-MAM dimension. Findings: Patient-related factors included beliefs about medications as important for self and faith; the desire to follow the advice of family, friends, and influential others; and self-efficacy. Social/economic factors included observations of social network members and information received from them; social support for medication adherence and pharmacy utilization; and economic influences. Therapy-related barriers included side effects and medicine schedules. Only a few participants mentioned condition-related factors. Healthcare system/healthcare team-related factors included support from doctors and pharmacists; and ease of pharmacy access and utilization. Conclusion: These results underscore the need for multidimensional interventions aimed at improving medication adherence and overall health of patients with CHD and CHD risk factors.
机译:背景:少数定性研究探索了影响冠心病(CHD)或CHD危险因素的人们中药物依从性的因素。我们探讨了与患者(例如自我效能感)相关的因素,社会/经济条件(例如,社会支持和药物成本),治疗(例如副作用),健康状况(例如,合并症)和医疗保健系统/医疗保健团队(例如来自医疗保健提供者和药房访问的支持)根据世界卫生组织多维依赖模型(WHO-MAM)影响药物遵守。方法:我们从2018年4月到2018年7月进行了18名深入定性访谈,随着≥45岁(8名黑人男子,5名黑人女性,2个白人男子和3名白人女性),他正在使用用于糖尿病,高血压的药物,血脂血症和/或CHD。我们使用主题分析来分析数据,并且在每个WHO-MAM维度内出现的子主题。调查结果:与患者相关的因素包括对自我和信仰的重要性的信念;愿望遵循家庭,朋友和影响他人的建议;和自我效能。社会/经济因素包括对社会网络成员的观察和从中收到的信息;社会支持药物遵守和药房利用;和经济影响。相关障碍包括副作用和医学时间表。只有少数参与者提到了与病情有关的因素。医疗保健系统/医疗团队相关因素包括医生和药剂师的支持;并且易于药房访问和利用。结论:这些结果强调了旨在改善CHD和CHD危险因素患者药物依从性和整体健康的多维干预措施的需求。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号